Atlas Trials

Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Clinical trial NCT03579602 · COMPLETED

Trial details

NCT number
NCT03579602
Sponsor
Blaze Bioscience Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Pediatric Central Nervous System Tumor
Start date
2018-11-26
Primary completion
2022-04-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.